Chemotherapy selection through the process of gastric cancer.
- Author:
Tian-Shu LIU
1
Author Information
1. Department of Medical Oncology, Fudan University, Shanghai, China. liu.tianshu@zs-hospital.sh.cn
- Publication Type:Journal Article
- MeSH:
Antineoplastic Combined Chemotherapy Protocols;
administration & dosage;
therapeutic use;
Chemotherapy, Adjuvant;
Humans;
Stomach Neoplasms;
drug therapy
- From:
Chinese Journal of Gastrointestinal Surgery
2012;15(2):118-120
- CountryChina
- Language:Chinese
-
Abstract:
The role of chemotherapy has become more and more important in the whole process of gastric cancer. S-1 or XELOX regimen is regarded as the standard treatment option in adjuvant chemotherapy. First-line chemotherapy in advanced gastric cancer has been established to improve survival, and the benefit from second-line chemotherapy is being acknowledged. More studies are needed to assess the neoadjuvant chemotherapy.
